OPKO Health PE Ratio 2010-2024 | OPK
Current and historical p/e ratio for OPKO Health (OPK) from 2010 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. OPKO Health PE ratio as of May 08, 2024 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
OPKO Health PE Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | TTM Net EPS | PE Ratio |
2024-05-09 | 1.26 | 0.00 | |
2024-03-31 | 1.20 | $-0.23 | 0.00 |
2023-12-31 | 1.51 | $-0.25 | 0.00 |
2023-09-30 | 1.60 | $-0.27 | 0.00 |
2023-06-30 | 2.17 | $-0.27 | 0.00 |
2023-03-31 | 1.46 | $-0.38 | 0.00 |
2022-12-31 | 1.25 | $-0.44 | 0.00 |
2022-09-30 | 1.89 | $-0.44 | 0.00 |
2022-06-30 | 2.53 | $-0.29 | 0.00 |
2022-03-31 | 3.44 | $-0.18 | 0.00 |
2021-12-31 | 4.81 | $-0.05 | 0.00 |
2021-09-30 | 3.65 | $0.11 | 33.18 |
2021-06-30 | 4.05 | $0.11 | 36.82 |
2021-03-31 | 4.29 | $0.19 | 22.58 |
2020-12-31 | 3.95 | $0.05 | 79.00 |
2020-09-30 | 3.69 | $-0.18 | 0.00 |
2020-06-30 | 3.41 | $-0.33 | 0.00 |
2020-03-31 | 1.34 | $-0.48 | 0.00 |
2019-12-31 | 1.47 | $-0.52 | 0.00 |
2019-09-30 | 2.09 | $-0.39 | 0.00 |
2019-06-30 | 2.44 | $-0.29 | 0.00 |
2018-12-31 | 3.01 | $-0.27 | 0.00 |
2018-09-30 | 3.46 | $-0.52 | 0.00 |
2018-06-30 | 4.70 | $-0.61 | 0.00 |
2018-03-31 | 3.17 | $-0.68 | 0.00 |
2017-12-31 | 4.90 | $-0.64 | 0.00 |
2019-03-31 | 2.61 | $-0.32 | 0.00 |
2017-09-30 | 6.86 | $-0.22 | 0.00 |
2017-06-30 | 6.58 | $-0.17 | 0.00 |
2017-03-31 | 8.00 | $-0.11 | 0.00 |
2016-12-31 | 9.30 | $-0.07 | 0.00 |
2016-09-30 | 10.59 | $-0.03 | 0.00 |
2016-06-30 | 9.34 | $0.25 | 37.36 |
2016-03-31 | 10.39 | $0.14 | 74.21 |
2015-12-31 | 10.05 | $-0.10 | 0.00 |
2015-09-30 | 8.41 | $-0.22 | 0.00 |
2015-06-30 | 16.08 | $-0.58 | 0.00 |
2015-03-31 | 14.17 | $-0.55 | 0.00 |
2014-12-31 | 9.99 | $-0.40 | 0.00 |
2014-09-30 | 8.51 | $-0.32 | 0.00 |
2014-06-30 | 8.84 | $-0.38 | 0.00 |
2014-03-31 | 9.32 | $-0.33 | 0.00 |
2013-12-31 | 8.44 | $-0.33 | 0.00 |
2013-09-30 | 8.81 | $-0.29 | 0.00 |
2013-06-30 | 7.10 | $-0.15 | 0.00 |
2013-03-31 | 7.63 | $-0.18 | 0.00 |
2012-12-31 | 4.81 | $-0.01 | 0.00 |
2012-09-30 | 4.18 | $-0.04 | 0.00 |
2012-06-30 | 4.60 | $-0.03 | 0.00 |
2011-12-31 | 4.90 | $-0.01 | 0.00 |
2011-09-30 | 4.33 | $-0.08 | 0.00 |
2011-06-30 | 3.69 | $-0.08 | 0.00 |
2011-03-31 | 3.73 | $-0.09 | 0.00 |
2010-12-31 | 3.67 | $-0.10 | 0.00 |
2012-03-31 | 4.73 | $-0.11 | 0.00 |
2010-09-30 | 2.24 | $-0.12 | 0.00 |
2010-06-30 | 2.26 | $-0.09 | 0.00 |
2010-03-31 | 1.98 | $-0.11 | 0.00 |
2009-12-31 | 1.83 | $-0.12 | 0.00 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Instruments Manufacturing | $0.871B | $0.864B |
OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Thermo Fisher Scientific (TMO) | United States | $218.968B | 26.53 |
Intuitive Surgical (ISRG) | United States | $134.917B | 81.28 |
Edwards Lifesciences (EW) | United States | $51.275B | 33.37 |
DexCom (DXCM) | United States | $50.673B | 76.76 |
IQVIA Holdings (IQV) | United States | $41.520B | 24.09 |
IDEXX Laboratories (IDXX) | United States | $40.226B | 47.15 |
Alcon (ALC) | Switzerland | $39.621B | 29.22 |
STERIS (STE) | Ireland | $20.760B | 24.26 |
Waters (WAT) | United States | $19.208B | 28.23 |
Hologic (HOLX) | United States | $17.704B | 19.81 |
SONOVA HOLDING (SONVY) | Switzerland | $17.503B | 0.00 |
ShockWave Medical (SWAV) | United States | $12.413B | 77.25 |
Fresenius Medical Care AG KGaA (FMS) | Germany | $12.136B | 14.16 |
Sysmex ADR (SSMXY) | Japan | $10.805B | 33.88 |
Teleflex (TFX) | United States | $9.442B | 14.70 |
Globus Medical (GMED) | United States | $8.357B | 24.50 |
Penumbra (PEN) | United States | $7.873B | 89.47 |
Masimo (MASI) | United States | $6.371B | 36.70 |
Glaukos (GKOS) | United States | $5.385B | 0.00 |
TransMedics (TMDX) | United States | $4.190B | 397.56 |
Integer Holdings (ITGR) | United States | $3.791B | 22.90 |
LivaNova (LIVN) | United Kingdom | $3.380B | 20.07 |
PROCEPT BioRobotics (PRCT) | United States | $3.104B | 0.00 |
Elekta AB (EKTAY) | Sweden | $2.779B | 19.07 |
Tandem Diabetes Care (TNDM) | United States | $2.722B | 0.00 |
Inari Medical (NARI) | United States | $2.431B | 0.00 |
Nihon Kohden (NHNKY) | Japan | $2.421B | 20.48 |
RxSight (RXST) | United States | $2.244B | 0.00 |
Integra LifeSciences Holdings (IART) | United States | $1.963B | 8.56 |
Veracyte (VCYT) | United States | $1.538B | 0.00 |
Alphatec Holdings (ATEC) | United States | $1.483B | 0.00 |
Artivion (AORT) | United States | $0.972B | 93.20 |
AVANOS MEDICAL, INC (AVNS) | United States | $0.898B | 17.46 |
OrthoPediatrics (KIDS) | United States | $0.791B | 0.00 |
Paragon 28 (FNA) | United States | $0.788B | 0.00 |
Silk Road Medical (SILK) | United States | $0.759B | 0.00 |
SiBone (SIBN) | United States | $0.618B | 0.00 |
Mesa Laboratories (MLAB) | United States | $0.611B | 20.73 |
ORTHOFIX MEDICAL INC (OFIX) | United States | $0.557B | 0.00 |
IRadimed (IRMD) | United States | $0.550B | 30.79 |
Pacific Biosciences Of California (PACB) | United States | $0.458B | 0.00 |
Pulse Biosciences (PLSE) | United States | $0.381B | 0.00 |
Nevro (NVRO) | United States | $0.373B | 0.00 |
NeuroPace (NPCE) | United States | $0.362B | 0.00 |
Tactile Systems Technology (TCMD) | United States | $0.329B | 11.26 |
Sight Sciences (SGHT) | United States | $0.276B | 0.00 |
EDAP TMS S.A (EDAP) | France | $0.263B | 0.00 |
Treace Medical Concepts (TMCI) | United States | $0.259B | 0.00 |
AxoGen (AXGN) | United States | $0.257B | 0.00 |
AngioDynamics (ANGO) | United States | $0.236B | 0.00 |
Atossa Genetics (ATOS) | United States | $0.211B | 0.00 |
908 Devices (MASS) | United States | $0.197B | 0.00 |
Inogen (INGN) | United States | $0.194B | 0.00 |
CVRx (CVRX) | United States | $0.168B | 0.00 |
Alpha Tau Medical (DRTS) | Israel | $0.168B | 0.00 |
Accuray (ARAY) | United States | $0.166B | 0.00 |
ClearPoint Neuro (CLPT) | United States | $0.164B | 0.00 |
Delcath Systems (DCTH) | United States | $0.153B | 0.00 |
Semler Scientific (SMLR) | United States | $0.148B | 7.54 |
KORU Medical Systems (KRMD) | United States | $0.103B | 0.00 |
Spectral Diagnostics (EDTXF) | Canada | $0.092B | 0.00 |
Yubo Biotech (YBGJ) | China | $0.085B | 0.00 |
Neuronetics (STIM) | United States | $0.076B | 0.00 |
SEP Acquisition (SEPA) | United States | $0.070B | 0.00 |
EnVVeno Medical (NVNO) | United States | $0.068B | 0.00 |
Envoy Medical (COCH) | United States | $0.064B | 0.00 |
Sensus Healthcare (SRTS) | United States | $0.063B | 127.67 |
Monogram Orthopaedics (MGRM) | United States | $0.060B | 0.00 |
Hyperfine (HYPR) | United States | $0.058B | 0.00 |
Autonomix Medical (AMIX) | United States | $0.058B | 0.00 |
InspireMD (NSPR) | Israel | $0.049B | 0.00 |
DarioHealth (DRIO) | United States | $0.048B | 0.00 |
Lucid Diagnostics (LUCD) | United States | $0.047B | 0.00 |
Vicarious Surgical (RBOT) | United States | $0.045B | 0.00 |
ReWalk Robotics (LFWD) | Israel | $0.044B | 0.00 |
LENSAR (LNSR) | United States | $0.039B | 0.00 |
Aspira Women's Health (AWH) | United States | $0.037B | 0.00 |
Pixie Dust Technologies (PXDT) | Japan | $0.036B | 0.00 |
Precision Optics (POCI) | United States | $0.035B | 0.00 |
Rapid Micro Biosystems (RPID) | United States | $0.034B | 0.00 |
Spectral AI (MDAI) | United States | $0.030B | 0.00 |
Inspira Technologies OXY B.H.N (IINN) | Israel | $0.026B | 0.00 |
Ekso Bionics Holdings (EKSO) | United States | $0.025B | 0.00 |
PAVmed (PAVM) | United States | $0.021B | 0.00 |
Accelerate Diagnostics (AXDX) | United States | $0.020B | 0.00 |
QT Imaging Holdings (QTI) | United States | $0.017B | 0.00 |
T2 Biosystems (TTOO) | United States | $0.017B | 0.00 |
Biosig Technologies (BSGM) | United States | $0.014B | 0.00 |
NexGel (NXGL) | United States | $0.014B | 0.00 |
Microbot Medical (MBOT) | United States | $0.013B | 0.00 |
Check-Cap (CHEK) | Israel | $0.013B | 0.00 |
Avinger (AVGR) | United States | $0.006B | 0.00 |
Venus Concept (VERO) | Canada | $0.004B | 0.00 |
ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
Tenon Medical (TNON) | United States | $0.003B | 0.00 |
Dynatronics (DYNT) | United States | $0.002B | 0.00 |
ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
Nuwellis (NUWE) | United States | $0.002B | 0.00 |
Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
SINTX TECHNOLOGIES, INC (SINT) | United States | $0.001B | 0.00 |
Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |